Mangoceuticals (MGRX) Minority Interest (2024 - 2026)

Mangoceuticals has disclosed Minority Interest across 3 years of filings, most recently posting -$2118.0 for Q2 2026.

• In Q2 2026, Minority Interest fell 79.34% year-over-year to -$2118.0; the TTM figure through Jun 2026 stood at -$2118.0 (down 79.34% YoY), while the FY2025 annual figure was -$1542.0, down 42.65% from the prior year.
• Minority Interest came in at -$2118.0 for Q2 2026 at Mangoceuticals, down from -$1533.0 in the prior quarter.
• In the past five years, Minority Interest ranged from a high of -$36.0 in Q1 2024 to a low of -$2118.0 in Q2 2026.
• Average Minority Interest over 3 years is -$1162.2, with a median of -$1180.0 recorded in 2025.
• Year-over-year, Minority Interest tumbled 3175.0% in 2025 and plunged 30.03% in 2026.
• Over 3 years, Minority Interest stood at -$1081.0 in 2024, then tumbled by 42.65% to -$1542.0 in 2025, then plunged by 37.35% to -$2118.0 in 2026.
• Per Business Quant data, the three most recent Minority Interest figures were -$2118.0 in Q2 2026, -$1533.0 in Q1 2026, and -$1542.0 in Q4 2025.